Cargando…

Cochlear Lymph Fluid Signal Increase in Patients with Otosclerosis after Intravenous Administration of Gadodiamide

PURPOSE: Increased cochlear lymph fluid signals on three-dimensional fluid-attenuated inversion recovery (3D-FLAIR) images obtained several minutes after intravenous administration of a single dose of gadolinium-based contrast agent (IV-SD-GBCA) in a patient with severe retrofenestral type otosclero...

Descripción completa

Detalles Bibliográficos
Autores principales: NAGANAWA, Shinji, KAWAI, Hisashi, TAOKA, Toshiaki, SUZUKI, Kojiro, IWANO, Shingo, SATAKE, Hiroko, SONE, Michihiko, IKEDA, Mitsuru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Japanese Society for Magnetic Resonance in Medicine 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5608127/
https://www.ncbi.nlm.nih.gov/pubmed/26841857
http://dx.doi.org/10.2463/mrms.mp.2015-0121
_version_ 1783265389531103232
author NAGANAWA, Shinji
KAWAI, Hisashi
TAOKA, Toshiaki
SUZUKI, Kojiro
IWANO, Shingo
SATAKE, Hiroko
SONE, Michihiko
IKEDA, Mitsuru
author_facet NAGANAWA, Shinji
KAWAI, Hisashi
TAOKA, Toshiaki
SUZUKI, Kojiro
IWANO, Shingo
SATAKE, Hiroko
SONE, Michihiko
IKEDA, Mitsuru
author_sort NAGANAWA, Shinji
collection PubMed
description PURPOSE: Increased cochlear lymph fluid signals on three-dimensional fluid-attenuated inversion recovery (3D-FLAIR) images obtained several minutes after intravenous administration of a single dose of gadolinium-based contrast agent (IV-SD-GBCA) in a patient with severe retrofenestral type otosclerosis had been reported. This increase was thought to represent breakdown of the blood-labyrinthine barrier. The purpose of this study was to evaluate cochlear lymph signal on heavily T(2)-weighted 3D-FLAIR (HF) images obtained 4 hours after IV-SD-GBCA in patients with otosclerosis, Ménière’s disease, and healthy subjects. MATERIALS AND METHODS: Twenty-two ears from 12 patients with otosclerotic plaques determined by computed tomography (CT), 16 ears from 8 healthy volunteers, and 10 ears from 9 Ménière’s disease patients with significant endolymphatic hydrops on magnetic resonance (MR) images were retrospectively analyzed. Images were obtained 4 hours after IV-SD-GBCA. Patients and healthy volunteers underwent MR cisternography (MRC) for anatomical reference of the fluid space and HF at 3T. The region of interest (ROI) was manually drawn on MRC images around the scala tympani in the basal cochlear turn. The reference ROI was set in the cerebellum. ROIs were copied onto HF images and the signal intensity ratio (SIR) of cochlear perilymph to cerebellum was measured. Differences in the SIR on HF images among the three groups were tested by one-way analysis of variance (ANOVA). RESULTS: The mean SIR was 24.0 ± 10.1 in otosclerosis patients, 7.9 ± 1.5 in volunteers, and 11.6 ± 3.9 in Ménière’s disease patients. The mean SIR was significantly higher in the otosclerosis group than in the other groups (P < 0.001). In the otosclerosis group, there was a significant difference in the SIR between the retrofenestral type and the fenestral type (P = 0.033). CONCLUSIONS: In patients with otosclerosis, the SIR was higher than in Ménière’s disease patients or in healthy volunteers. The SIR was higher in the retrofenestral type than in the fenestral type.
format Online
Article
Text
id pubmed-5608127
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Japanese Society for Magnetic Resonance in Medicine
record_format MEDLINE/PubMed
spelling pubmed-56081272017-10-23 Cochlear Lymph Fluid Signal Increase in Patients with Otosclerosis after Intravenous Administration of Gadodiamide NAGANAWA, Shinji KAWAI, Hisashi TAOKA, Toshiaki SUZUKI, Kojiro IWANO, Shingo SATAKE, Hiroko SONE, Michihiko IKEDA, Mitsuru Magn Reson Med Sci Major Paper PURPOSE: Increased cochlear lymph fluid signals on three-dimensional fluid-attenuated inversion recovery (3D-FLAIR) images obtained several minutes after intravenous administration of a single dose of gadolinium-based contrast agent (IV-SD-GBCA) in a patient with severe retrofenestral type otosclerosis had been reported. This increase was thought to represent breakdown of the blood-labyrinthine barrier. The purpose of this study was to evaluate cochlear lymph signal on heavily T(2)-weighted 3D-FLAIR (HF) images obtained 4 hours after IV-SD-GBCA in patients with otosclerosis, Ménière’s disease, and healthy subjects. MATERIALS AND METHODS: Twenty-two ears from 12 patients with otosclerotic plaques determined by computed tomography (CT), 16 ears from 8 healthy volunteers, and 10 ears from 9 Ménière’s disease patients with significant endolymphatic hydrops on magnetic resonance (MR) images were retrospectively analyzed. Images were obtained 4 hours after IV-SD-GBCA. Patients and healthy volunteers underwent MR cisternography (MRC) for anatomical reference of the fluid space and HF at 3T. The region of interest (ROI) was manually drawn on MRC images around the scala tympani in the basal cochlear turn. The reference ROI was set in the cerebellum. ROIs were copied onto HF images and the signal intensity ratio (SIR) of cochlear perilymph to cerebellum was measured. Differences in the SIR on HF images among the three groups were tested by one-way analysis of variance (ANOVA). RESULTS: The mean SIR was 24.0 ± 10.1 in otosclerosis patients, 7.9 ± 1.5 in volunteers, and 11.6 ± 3.9 in Ménière’s disease patients. The mean SIR was significantly higher in the otosclerosis group than in the other groups (P < 0.001). In the otosclerosis group, there was a significant difference in the SIR between the retrofenestral type and the fenestral type (P = 0.033). CONCLUSIONS: In patients with otosclerosis, the SIR was higher than in Ménière’s disease patients or in healthy volunteers. The SIR was higher in the retrofenestral type than in the fenestral type. Japanese Society for Magnetic Resonance in Medicine 2016-02-03 /pmc/articles/PMC5608127/ /pubmed/26841857 http://dx.doi.org/10.2463/mrms.mp.2015-0121 Text en © 2016 Japanese Society for Magnetic Resonance in Medicine http://creativecommons.org/licenses/by/3.0/ This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives International License.
spellingShingle Major Paper
NAGANAWA, Shinji
KAWAI, Hisashi
TAOKA, Toshiaki
SUZUKI, Kojiro
IWANO, Shingo
SATAKE, Hiroko
SONE, Michihiko
IKEDA, Mitsuru
Cochlear Lymph Fluid Signal Increase in Patients with Otosclerosis after Intravenous Administration of Gadodiamide
title Cochlear Lymph Fluid Signal Increase in Patients with Otosclerosis after Intravenous Administration of Gadodiamide
title_full Cochlear Lymph Fluid Signal Increase in Patients with Otosclerosis after Intravenous Administration of Gadodiamide
title_fullStr Cochlear Lymph Fluid Signal Increase in Patients with Otosclerosis after Intravenous Administration of Gadodiamide
title_full_unstemmed Cochlear Lymph Fluid Signal Increase in Patients with Otosclerosis after Intravenous Administration of Gadodiamide
title_short Cochlear Lymph Fluid Signal Increase in Patients with Otosclerosis after Intravenous Administration of Gadodiamide
title_sort cochlear lymph fluid signal increase in patients with otosclerosis after intravenous administration of gadodiamide
topic Major Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5608127/
https://www.ncbi.nlm.nih.gov/pubmed/26841857
http://dx.doi.org/10.2463/mrms.mp.2015-0121
work_keys_str_mv AT naganawashinji cochlearlymphfluidsignalincreaseinpatientswithotosclerosisafterintravenousadministrationofgadodiamide
AT kawaihisashi cochlearlymphfluidsignalincreaseinpatientswithotosclerosisafterintravenousadministrationofgadodiamide
AT taokatoshiaki cochlearlymphfluidsignalincreaseinpatientswithotosclerosisafterintravenousadministrationofgadodiamide
AT suzukikojiro cochlearlymphfluidsignalincreaseinpatientswithotosclerosisafterintravenousadministrationofgadodiamide
AT iwanoshingo cochlearlymphfluidsignalincreaseinpatientswithotosclerosisafterintravenousadministrationofgadodiamide
AT satakehiroko cochlearlymphfluidsignalincreaseinpatientswithotosclerosisafterintravenousadministrationofgadodiamide
AT sonemichihiko cochlearlymphfluidsignalincreaseinpatientswithotosclerosisafterintravenousadministrationofgadodiamide
AT ikedamitsuru cochlearlymphfluidsignalincreaseinpatientswithotosclerosisafterintravenousadministrationofgadodiamide